Table 3.
Inflammatory bowel disease outcomes of transition n (%)
| Transition cohort | Non-transition cohort | P value | |
| Medication (self-reported) | |||
| 5-aminosalicylic acid | 19 (41) | 14 (41) | 1.00 |
| Sulfasalazine | |||
| Mesalazine | |||
| Immunomodulator | 30 (65) | 25 (71) | 0.63 |
| Azathioprine/6 | 27 | 24 | |
| Mercaptopurine | |||
| Methotrexate | 3 | 1 | |
| Biologic therapy (anti-TNF) | 8 (17) | 9 (26) | 0.42 |
| Infliximab | 6 | 5 | |
| Adalimumab | 2 | 4 | |
| Non-compliance | 3 (7) | 4 (11) | 0.46 |
| Perianal disease | 9 (20) | 8 (24) | 0.79 |
| Complications (Perforation, bowel obstruction, stricture) | 12 (26) | 5 (14) | 0.27 |
| Surgery (Resection +/- stoma, fistula with seton) | 15 (33) (9 prior to transition) | 10 (29) | 0.81 |
| Number of hospital admissions per patient (median) | |||
| During paediatric care | 3.2 | N/A | |
| During adult care | 1.5 | 2.1 | 0.67 |
| Number of flares requiring steroids per patient (median) | |||
| Since transition | 0.5 | N/A | |
| During last year | 0.5 | 1 | 0.31 |
| Extra intestinal manifestations of IBD (Arthropathy/Cutaneous/Ocular/Hepatobiliary/Metabolic bone disease)1 | 6 (14) | 8 (24) | 0.37 |
| IBD symptoms | |||
| Physical | 39 (85) | 33 (94) | 0.29 |
| Psychological | 16 (35) | 16 (46) | 0.36 |
| Social | 29 (63) | 26 (76) | 0.23 |
| MDT utilisation | |||
| General Practitioner | 34 (74) | 25 (69) | 0.80 |
| Psychologist | 2 (4) | 3 (8) | 0.65 |
| Dietician | 9 (20) | 7 (19) | 1.00 |
| Colorectal surgeon | 12 (26) | 11 (31) | 0.80 |
| IBD nurse | 11 (24) | 19 (25) | 0.01 |
| Relationship status | |||
| Single | 22 (48) | 17 (49) | 1.00 |
| In a relationship | 20 (43) | 12 (34) | 0.49 |
| Married | 4 (9) | 6 (17) | 0.32 |
| Divorced | 0 (0) | 0 (0) | 1.00 |
| Education (level completed) | |||
| Primary | 43 (100) | 35 (100) | 1.00 |
| Secondary | 38 (88) | 27 (77) | 0.23 |
| Tertiary | 19 (41) | 5 (14) | 0.01 |
| TAFE (Technical and further education) | 8 (17) | 12 (34) | 0.12 |
| Apprenticeship/trade | 6 (13) | 7 (20) | 0.54 |
| Employment | |||
| Currently employed | 35 (76) | 21 (60) | 0.15 |
| Full-time employment | 21 (60) | 11 (52) | 0.59 |
| Average hours worked/week | 29.8 | 34.2 |
1
Mouth ulcers were omitted. IBD: Inflammatory bowel disease.